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847-4 Enhanced External Counterpulsation Reduces Angina 
and Improves Quality of Life in Elderly 
Unrevsscularizable Patients 
Georeiann C. Linnemeier, Elizabeth O. Kennard, William E. Lawson, University of 
Pittsburgh, Pittsburgh, Pennsy/vania. 
Background: When treating eldedy patients (E) (>75 years) with symptomatic oronary 
artery disease (CAD), it is unclear whether the acute risks of revasculadzatlon are coun- 
terbalanced by better long-term survival or functional outcomes. Enhanced external 
counterpulsation (EECP) is a noninvasive treatment similar to the intra-aortic balloon 
pump, which is designed to increase myocardial perfusion pressure and decrease car- 
diac workload. EECP has been demonstrated to be safe and effective in treating angina; 
however, whether it is safe and effective in E who are not considered candidates for fur- 
ther revascu(adzation is unknown. 
Methods: The study group consisted of 550 patients consecutively enrolled in the Inter- 
national EECP Patient Registry who were ~ 75 years and not considered candidates for 
further revasculadzation. 
Results: The mean age was 79.9 (+ 4.4 years). Most patients had prior revascularization: 
72% prior coronary artery bypass graft surgery, 58% prior percutanecus coronary inter- 
vention. Mean left ventricular ejection fraction was 45%, and 23% of E had an ejection 
fraction <35%. Multivessel disease was present in 85% of patients, with 87% of E report- 
ing Canadian Cardiovascular Society (CCS) angina class III or IV. Treatment was com- 
pleted as prescribed in 80% of patients, with a mean of 32 treatment hours. The rate of 
major adverse cardiac events during treatment was low (<3%). Upon completion of 
EECP treatment, E reported: significant reduction in angina (mean CCS class, pre- 3.1 
vs. post- 1.9), and significant reduction in episodes of angina (mean episodes/week, pre- 
9.4 vs. post- 2.4) and nitroglycerin use (mean, pre- 9.4 vs. post- 2.7). Of 74% of E using 
nitroglycerin at the start of treatment, 42% of E required nitroglycerin post-EECP treat- 
ment. Patient assessed quality of life scores were also significantly improved post-treat- 
ment. All changes, pre-and post-EECP were statistically significant with p<0.001. 
Conclusion: Symptomatic CAD in elderly patients is of immense public health and eco- 
nomic importance. In the group of elderly patients who are unsuitable for revasculariza- 
tion, EECP provides an innovative tool that improves functional outcome and quality of 
life. 
9:30 a.m. 
847-5 White Coat Hypertension Increases Cardiovascular 
Risk in Elderly 
Jose A. Aizourua. Tulle A. Sulbaran, Egle Silva, Gladys Maestre, Centre de 
Enfermedades Cardiovasoulares, Maracaibo, Venezuela, La Universidad e/Zulia, 
Maracaibo, Venezue/a. 
Background: There are no long-term follow up studies about white coat hypertension 
(WCH) in Venezuela; on the other hand there is a controversy about the risk provided by 
this condition. The aim of this study was to establish the prognostic value of Ambulatory 
Monitoring Blood Pressure (ABPM) for cardiovascular (CV) morbidity in elderly. 
Method,=: The study included a sample of 609 subjects older than 55 years who under- 
went non-invasive ABPM when enrolled in the study and were prospectively followed 
since that moment until a nonfatal cardiovascular event occurs or the ending of the study. 
The maximal follow up time was 31.5 months (mean 20). 
Results: The comparison between morbidity rates showed a significant difference 
among normctensive (1.04 per 100 pac/yr), WCH (8.99 per 100 pac/yr) and ambulatory 
hypertension (16.76 per 100 pec/yr) groups (p < 0.01). The difference between survival 
curves was highly significant FIG 1. Night systolic ABP showed the best independent 
predictive power for CV events. Diastolic pressures were not associated to cardiovascu- 
lar events dsk. The risk for morbidity in WCH group was increased compared with that of 
normotensive group (RR 8.65; CI 95% 3.03 - 24.68; p < 0.01). Nondippers showed an 
increased risk compared to dippers (RR 1.73; CI 95% 1.03 - 2.88; p 0.03). 
Conclusion: In this elderly population, WCH is not a benign condition, but must be con- 
sidered as an important CV risk factor. Nondipper pattern showed predictive power in 
whole population for both sexes. 
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847-6 Outcome of Elderly Women With Refractory Chronic 
Angina Treated Invasively Versus Medically: 
Comparison With Elderly Men In the Prospective 
Randomized Trial of  Invasive Versus Medical Therapy in 
the Elderly (TIME) 
Gabriela M. Kuster, Matthias Pfistersr, for the TIME Investigators, University Hospital, 
Basel, Switzerland. 
Background: Women >75 years of age represent almost half the elderly coronary artery 
disease (CAD) population, yet they are severely underrepresented inclinical trials. 
Patients and Methods: We prospectively randomized 301 patients age >75 years with 
angina CCS class II-IV despite at least two antianginal drugs to coronary angiography 
and revasculadzation or to optimized medical therapy. Six months outcome assessed as 
quality of life (QoL: SF 36, Rose, Duke Activity Score Index) and adverse events (AE: 
death, myocardial infarction (MI) or hospitalisation for acute coronary syndrome) were 
compared between women and men as prespecified subgroups of the TIME study. 
Results: 44% (n=131) of the 301 patients were women. Age was 80±4 years (mean±SD) 
in both genders. More women were hypertensive (70% vs. 55%, p--0,006), and fewer 
smoked (12 vs. 51%, p<0,0001). Although angina sevedty (CCS class Ill-IV in 82% vs. 
75% of the men, n.s,) and history of prior MI (44 vs. 49%, n.s.) were similar, the rate of 
prior revasculafizations was lower in women (6% vs. 29%, p<0.001) and fewer coronary 
vessels were diseased (p<0.00t). In addition, left ventricular ejection fraction was higher 
in women (55±12 vs. 51±12, p=0.05). Despite these findings, women judged their QoL at 
baseline inferior than men (p<0.01 except for Rose). During follow-up, they showed a 
similar improvement in QoL on therapy as men, but overall, QoL remained worse in 
women. AE occurred more often in women than in men with more deaths (]o=0.03) and a 
higher rate of death and MI (p=0.01). The subgroup of medically treated women (n=64) 
suffered more AE (p<0,003), particulady non-fatal ischemic events (p<0.001) than 
women in the invasive subgroup (n=67). 
Conclusions: Eldedy women with chronic angina differ importantly from eldedy man in 
disease presentation, perception and outcome: despite similar angina and lower disease 
severity, they judge their QoL worse than men and their outcome is worse than that of 
men. Still, they benefit from revascularisation similarly. These findings suggest that other 
mechanisms than CAD severity may be relevant in determining weU-being and outcome 
in women. 
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11 56-141 Cytotoxic Aldehydes Aggravate Ventricular Dysfunction 
in an Injured Heart: Evidence From an Iron Overload 
Model of Heart Failure 
Mehrdad Yazdanpanah, Gavin Oudit, Andrea Lee, Fayez Dawood, Wen-Hu Wan, Peter 
Beckx, Peter Liu. Heart & Stroke~Richard Lewar Centre of Excellence, U of Toronto, 
Toronto, Ontario, Canada, Toronto General Hospital, UHN, Toronto, Ontario, Canada. 
BACKGROUND: Cytotoxic aldehydes, by-products of oxidative stress, are increased in 
heart failure in general, and in iron ovedoad cardiomyopathy in particular. We tested the 
hypothesis that increased aldehydes exert a direct negative influence on heart function in 
an established iron overload heart failure model. 
METHODS: On the background of cardiac iron overload, we augmented aldehyde levels 
by selective inhibition of tissue aldehyde dehydrogenase (ALDH) with disulfirem (Dis, 40 
mg/kg ip od), cyanamide (Cyn, 50 mg/kg ip od), or administration of 12 straight chain 
aldehydes (0.1 mL, 2.5 raM, ip) for 3 months in B6D2Flmice, and assessed aldehyde 
levels together with invasive and no-invasive measures of LV function. Mice were ran- 
domized to either control (C), iron load (Fe) alone or iron load with ALDH inhibitor (AIdl). 
RESULTS: Serum aldehydes increased further with ALDH inhibition (Hexanol, nmoVL, 
C:134±15 vs, Fe:261±37 vs. Dis:342±26, M±SEM, p<0.05). In rive hemodynamics using 
a Millar catheter displayed lower LV systolic pressure with ALDH inhibition (C: 96±4 vs. 
Fe: 74±3 vs Cyn: 64±2 mmHg, p<0.05, and similarly with disulfiram). FJA ratio was also 
decreased with Aldl (C:1,4±.2 vs. Fe: 1,2±.2 vs. Dis: 1.0¢.3, p<0.05). With aldehyde infu- 
sions, both +dP/dt and -dP/dt were lower (2815±547 vs 5618±776 (C), 2293±219 vs 
4255¢376 (C), p<0.05). 
CONCLUSION: The increased levels of serum aldehydes with either ALDH inhibition or 
direct infusion led to further depression of both systolic and diastolic function, suggesting 
oxidative stress contributes to the LV dysfunction in the setting of cardiac injury, and is 
not merely an innocent bystander. 
1156-142 NF-kB Activation Is Involved in Inflammatory Skeletal 
Muscle Alterations In Patients With Chronic Heart 
Failure 
Vglker Adams. Uldke Sp&te, Nicolle Kr&nkel, Gerhard Schuler, Rainer Hambrecht, 
University Leipzig, Heart Center Leipzig, Leipzig, Germany. 
Background: In advanced stages of chronic heart failure (CHF) the expression of induc- 
ible nitric oxide synthase (iNOS) in skeletal muscle (SM) may contdbute to exercise intol- 
erance and early fatigue. In vitro studies and promoter analysis demonstrated that the 
:Z: 
u~ 
c3 
C~ 
176A ABSTRACTS - Cardiac Function and Hear t  Fa i lu re  
transcription factor NF-kB is essential for the transcription of iNOS. The aim of this study 
was to assess wether NF-kB is activated in skeletal muscle of patients (pts) with CHF 
and linked to the expression of iNOS. 
Methods: Skeletal muscle biopsies were obtained from 7 CHF-pts (NYHA I1-~11; LVEF 19 
± 2%; VO2max 14.0 ± 1.3 ml/kg/min) and 7 healthy controls (HC) (LVEF 71 ± 2%; 
VO2max 28.3 ± 2.7 ml/kg/min). Nuclear proteins were isolated and the content of acti- 
vated NF-kB was analyzed by etectrophoretic mobility shift assay (EMSA). iNOS expres- 
sion in SM was determined by real time PCR and TNF-a concentration in the serum was 
measured by ELISA. 
Results: The expression of [NOS and the activation of NF-kB in the SM was significantly 
increased in CHF pts as compared to healthy controls (iNOS: 0.30 ± 0.04 vs. 0.09 ± 0.03 
relative RNA expression, p<0.01; NF-kB: 0.48 ± 0.10 vs. 0.12 ± 0.05 relative units). Addi- 
tionally serum TNF-a was significantly increased in CHF pts (CHF: 5.2 ± 0.6 vs. HC: 1.5 
± 0.2 pg/ml; p<O.001 ). Furthermore, a signifcant linear correlation was observed between 
NF-kB activation and iNOS expression (r--0.71, p<0.01) as well as between serum TNF- 
a and NF-kB activation ( r--O.8, p<0.01) 
Conclusion: The results of this study indicate for the first time that in skeletal muscle of 
patients with chronic heart failure the activation of transcription factor NF-kB is increased 
and may represent one important regulatory factor for the expression of )NOS. 
1156-143 Exposure  o f  Normal Adult Cediomyocytes to Active 
Caepaae-8 Triggers the Release of Cytochrome C From 
MItochondria Suppresses Mitochondrial Respiration 
Victor G. Sharov. Anastassia V. Tedor, Sidney Goldstein, Hani N. Sabbah, Henry Ford 
Health System, Detroit, Michigan. 
Background: We previously showed that mitochondrtal respiratory abnormalities exist in 
cardiomyocytes of human with end-stage heart failure as well as in cardiomyocytes of 
dogs with intracoronary microembolization-induced chronic heart failure. The factors that 
promote these abnormalities remain uncertain. One possible factor is activation of 
caspase-8 which, by activating Bid, promotes the release of cytochrome c from mlto- 
chondria that, in turn, results in mitochondrial dysfunction. In the present study, we tested 
the hypothesis that exposure of normal adult cardiomyocytes to active caspase-8, acti- 
vates bid, causes the release of cytochrome c from mitochondria nd adversely impacts 
mitochondrial respiration. 
Methods: Cardiomyocyte were enzimatically isolated from left ventdcular myocardium of 
5 normal dogs. Cardiomyocytes were saponin skinned, incubated under normoxic condi- 
tions (95%air/5%CO2), and exposed to active caspase-8 (100U/mr) for one hour. All- 
quotes of cardiomyocytes incubated with and without active caspase-8 were used to 
measure mitochondrial state 3 respiration with Clark electrode in the presence of 3 mM 
malate, 5 mM glutamate and 1 mM ADP. A second set of aliquotes of cardiomyocytes 
was centrifuged at 15,000 g and the supernatant used to measure the expression of 
cytosolic cytoohrome c and a third set was homogenized and the homogenate used to 
measure the expression of Bid by Western blotting. 
Results: Exposure of cardiomyocytes to active caspase-8 resulted in cleavage of Bid 
into 15 kDa fragments and markedly increased cytosolic cytochrome c (2.4 + 0.3 vs. 25.2 
_-t: 0.8, P<0.001) compared to unexposed cardiomyocytes. Exposure to caspase-8 also 
caused a significant decrease in mltochondrial state 3 respiration (39 -+ 4 vs. 64 -+ 13 ng 
atoms O2imin/mg protein, P<0.001 ). 
Conclusions: These results indicate that exposure of normal adult cardiomyocytes to 
active caspasa-8 triggers cleavage of Bid and the release of cytochrome c from mito- 
chondria with subsequent suppression of state respiration. This cascade of events offers 
an explanation for the observed abnormalities of mitochondrial respiration seen in heart 
failure. 
1156-144 Th io redox ln :  A New Marker of  Ox idat ive  St ress  in 
Patients With Chronic Heart Failure 
Andraas Jekell, Akter Hossain, Anders Rosdn, Ulf Dahlstrdm, LinkSping University, 
Link6ping, Sweden. 
Background: It is well known that pro-inflammatory cytokines are important prognostic 
markers in chronic heart failure (CHF) patients and it has been shown that tumor necro- 
sis factor-~x (TNFc¢) is elevated in plasma of CHF patients. Elevated levels of TNF~ are 
correlated with New York Heart Association (NYHA) functional class. Thioredoxin (Trx) is 
a multifunctional redox-protein, which regulate the intra- and extra cellular redox-environ- 
ment. One important function of Trx is the protection from oxidative stress caused by free 
radicals and pro-inflammatory cytokines. Trx is upregulatad both during chronic and 
acute oxidative conditions. However, it is not known whether Tr'x is elevated in systemic 
circulation in patients suffering from CHF. The aim of this study was to investigate possi- 
ble mechanisms behind CHF with special emphasis on the activation of cytokines and to 
see whether oxidative stress was playing a role. In order to assess these complex pro- 
cesses in CHF, we analyzed plasma levels of the redox-active proteins Trx and Trx- 
reductase (TrxR) as markers of oxidative stress and TNF(x and intedeukin 6 (IL6) as pro- 
inflammatory cytokines. 
Methoda: 27 male patients with CHF, NYHA class I1-111, and mean age 74 _+ 5 years 
(range 65-82) were compared to 30 healthy subjects of similar age-groups, mean age 75 
_+ 5 years (range 64 - 81). Plasma samples were collected in the morning after rest for 30 
min in supine position and analyzed in enzyme-linked immunosorbent assays (ELISA) for 
TNF, Trx, TrxR and IL6. 
Results: Patients with CHF showed a significant increase of Trx in plasma, mean 32 +__5 
(SEM) ng/ml, compared to healthy subjects (16 +4 ng/ml); p < 0.0001. Variations of 
plasma Trx were found in patients with CHF (range 9-101 ng/ml) as well as in healthy 
subjects (range 4-117 ng/ml). No significant differences in TNF~, IL6 nor TrxR concentra- 
tions were seen between the two groups. 
Conclusions: The most important finding in our pilot study is that Trx was significantly (p 
JACC March  6 ,  2002 
< o.o0ol) elevated in patients with CHF compared to healthy subjects of similar age 
groups. This finding indicates that Trs may be a new sensitive marker of oxidative stress 
in CHF. 
1156-145 Anticytokine Therapy Alleviates Oxidative Stress and 
Attenuates Left Ventricular Remodeling in Experimental 
Heart  Fa i lure 
Gordon W. Moe, Andrea Konig, Marina Romanova, Peter Liu, St Michael's Hospital, 
Toronto, Ontario, Canada, University Health Network, Toronto. Ontario, Canada. 
Background: Increased expression of the prdmflammatory cytokine tumor necrosis fac- 
tor-alpha (TNF-(~) and increased oxidative stress have been observed in the failing head. 
TNF-c~ is known to induce oxidative stress /n vitro. Accordingly, this study tested the 
hypothesis that TNF-(x would also induce oxidative stress in vivo and contribute to LV 
dysfunction and remodeling in heart failure (HF). 
Methods: Dogs were randomly assigned to: (1) no pacing (controls, n=10), (2) chronic 
pacing for 4 weeks to severe HF (HF, n=10), and (3) pacing with concomitant reatment 
with etanercept, a chimeric TNF-~ soluble receptor, 0.5 mg/kg twice weekly SC (HF- 
etanercept, n=10). LV tissue level of aldehyde, an accurate marker of oxidative stess, 
was measured using gas chromatography/mass spectroscopy. LV function and remodel- 
ing was assessed by echocardlography. 
Results: LV tissue total aldehyde level increased markedly in HF, indicating severe oxi- 
dative stress. Selected unsaturated aldehydes such as 4-OH hexenal and malondialde- 
hyde were also increased. This was accompanied by reduced LV ejection fraction (LVEF) 
and increased LV volume (LVV), reflective of LV dysfunction and remodeling. Treatment 
with etanercept normalized LV aldehyde levels, reduced LVV, and partially restored 
LVEF. 
Conclusion: Our data provide supportive evidence that TNF.(x contributes to LV dys- 
function and remodeling in canine pacing-induced CHF, mediated in part by a local 
increase in oxidative stress. 
* p<O,OOl ve controls, ** p<O.O5 ve HF 
Controls HF HF-etanercept 
LVV (ml/kg) 3.4 + 0.5 5.2 + 0.4" 4.0 + 0.2** 
LVEF (%) 53 +_2 19 + 3* 26 + 2** 
Aldehydes (pmol/100 rag) 7048_+448 11760_+1410" 6991_+516"* 
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1157-153 A Simple Model to Predict Left Ventricular Systolic 
Dyefunction in a Multiethnic Community 
Gavin I. Gatasko, Roxy Senior, Avijit Lahid, Cardiology Research Department, Northwick 
Park Hospital, Harrow, United Kingdom. 
Background: Community-based programmes to screen for and treat left ventricular sys- 
tolic dysfunction (LVD) have recently been advocated. However, who best to invite for 
screening has not yet been fully elucidated. This study was undertaken to assess this fur- 
ther. 
Methods: 1403 subjects _> 45 years old were chosen at random from 7 geographical and 
socio-economically representative community practices to undergo a clinical assess- 
ment, symptom questionnaire, ECG, echocardiogram and fasting blood tests. A multi- 
variate model to predict the presence or absence of LVD was then constructed using 
both clinical and biochemical parameters. 
Results: 730 subjects (52%) attended. 515 (71%) were Caucasian and 168 (26%) South 
Asian. An ejection fraction (EF) was calculable by echocardiography using Simbson's 
apical biplane rule in 700 cases (96%). 38 subjects (5.4%) were found to have LVD. Of 
these 19 (50%) were entirely asymptomatic. Multivariate predictors of LVD included prior 
myocardial infarction, diabetes, a history of heavy alcohol usage, male sex, abnormal 
ECG and plasma N-terminal proBNP levels. No significant differences were seen with 
ethnicity. A multivariate model to predict LVD using these 6 parameters was constructed. 
It gave an area under the ROC curve of 0.95 for predicting significant LVD (EF <45%). A 
risk-score above 2.83 gave a sensitivity of 92% and specificity of 89% for predicting LVD, 
requiring only 14% of the population to undergo echocardiographic screening with a one- 
in-four pick up rate. 
Conclusion: Thus left ventdcular dysfunction is a common problem in multi-ethnic om- 
munities, has no racial difference in prevalence, is asymptomatic in half of cases, and 
has identifiable clinical and biochemical risk factors. Six simple clinical and biochemical 
markers can be used to successfully predict the presence or absence of LVD, potentially 
allowing a cost-effective targeted community-based echocardiographic screening pro- 
gramme for LVD. 
1157-154 Is Iso lated Diasto l ic  Heart  Fa i lure Tru ly  Stand Alone? 
Cheuk-Man Yu, Hong Lin, Hua Yang, Shun-Ling Kong, Steven Wai-Luen Lee, Chu-Pak 
Lau, The University of Hong Kong, Hong Kong, Hong Kong. 
Background: Definition of diastolic heart failure (DHF) relies on the use of sensitive tools 
to exclude the presence of systolic dysfunction. The use of ejection fraction of 50% as 
the cut-off point may not be adequate to address such task. We testify the hypothesis 
